Histogen Inc

Company Profile

Histogen Inc had its IPO on 2013-07-25 under the ticker symbol HSTO.

The company operates in the Healthcare sector and Biotechnology industry. Histogen Inc has a staff strength of 7 employees.

Stock update

Shares of Histogen Inc opened at $0.67 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.65 - $0.67, and closed at $0.66.

This is a +1.54% increase from the previous day's closing price.

A total volume of 1,670 shares were traded at the close of the day’s session.

In the last one week, shares of Histogen Inc have slipped by -2.94%.

Histogen Inc's Key Ratios

Histogen Inc has a market cap of $2.91 million, indicating a price to book ratio of 0.2472 and a price to sales ratio of 1.1104.

In the last 12-months Histogen Inc’s revenue was $19000 with a gross profit of $-1252000 and an EBITDA of $-11977000. The EBITDA ratio measures Histogen Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Histogen Inc’s operating margin was -63831.58% while its return on assets stood at -43.83% with a return of equity of -102.91%.

In Q2, Histogen Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Histogen Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-3.79 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Histogen Inc’s profitability.

Histogen Inc stock is trading at a EV to sales ratio of 2.8893 and a EV to EBITDA ratio of 0.5229. Its price to sales ratio in the trailing 12-months stood at 1.1104.

Histogen Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$13.54 million

Total Liabilities

$969000.00

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Histogen Inc ended 2024 with $13.54 million in total assets and $0 in total liabilities. Its intangible assets were valued at $13.54 million while shareholder equity stood at $9.29 million.

Histogen Inc ended 2024 with $0 in deferred long-term liabilities, $969000.00 in other current liabilities, 5000.00 in common stock, $-93835000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $7.26 million and cash and short-term investments were $7.26 million. The company’s total short-term debt was $275,000 while long-term debt stood at $0.

Histogen Inc’s total current assets stands at $8.27 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0.00 compared to accounts payable of $394000.00 and inventory worth $0.

In 2024, Histogen Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Histogen Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.66

52-Week High

$1.87

52-Week Low

$0.62

Analyst Target Price

$2

Histogen Inc stock is currently trading at $0.66 per share. It touched a 52-week high of $1.87 and a 52-week low of $1.87. Analysts tracking the stock have a 12-month average target price of $2.

Its 50-day moving average was $0.74 and 200-day moving average was $0.92 The short ratio stood at 3.37 indicating a short percent outstanding of 0%.

Around 285.3% of the company’s stock are held by insiders while 934.4% are held by institutions.